{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    6,
    8,
    17,
    20,
    25,
    26,
    29,
    37,
    38,
    39
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 0.8,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 1.3 Schedule of Activities (SoA), Table 1",
        "impactLevel": "Administrative",
        "instanceType": "StudyAmendmentImpact",
        "description": "Added a footnote to the Schedule of Activities to reference US-specific screening procedures detailed in Section 8."
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 4.2 Scientific Rationale for Study Design",
        "impactLevel": "Administrative",
        "instanceType": "StudyAmendmentImpact",
        "description": "Updated the number of days for zinc discontinuation effect to align with other protocol sections."
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 8 Study Assessments and Procedures",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Introduced the option for US sites to act as screening-only sites to facilitate participant recruitment. This change contributes to the amendment being classified as substantial."
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_3.1_US",
        "reasonText": "To clarify study procedures occurring across different sites in the US, so as to facilitate participant recruitment across different regions of the US, and to lessen inconvenience for participants without compromising the quality of the study.",
        "category": "Operational",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_3.1_US",
        "reasonText": "To align the number of days with the mention of zinc discontinuation elsewhere in the protocol.",
        "category": "Administrative",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_3.1_US",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "Text added to the footnote to state that procedures specific to screening sites (only in the US) are detailed in Section 8.",
        "summary": "A footnote was added to the Schedule of Activities (Table 1) to reference US-specific screening procedures."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_3.1_US",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2",
        "beforeText": "...the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 30 days after discontinuation of zinc.",
        "afterText": "...the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 21 days after discontinuation of zinc.",
        "summary": "Changed the timeframe for minimal zinc effect after discontinuation from 30 days to 21 days for consistency within the protocol."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_3.1_US",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "8",
        "afterText": "Addition of text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures.",
        "summary": "Added text to allow US sites to function solely as screening sites to improve recruitment."
      }
    ],
    "summary": {
      "impactCount": 3,
      "reasonCount": 2,
      "changeCount": 3
    }
  }
}